SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-23-129754
Filing Date
2023-12-27
Accepted
2023-12-27 17:02:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2333799d1_sc13da.htm SC 13D/A 31891
  Complete submission text file 0001104659-23-129754.txt   33305
Mailing Address C/O COUNSEL CORPORATION 700 - 1 TORONTO ST. TORONTO A6 M5C 2V6
Business Address
SILBER ALLAN C (Filed by) CIK: 0001009161 (see all company filings)

Type: SC 13D/A

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Subject) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91575 | Film No.: 231518645
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)